High-efficiency purification of divergent AAV serotypes using AAVX affinity chromatography

High-efficiency purification of divergent AAV serotypes using AAVX affinity chromatography

The adeno-associated viral vector (AAV) provides a safe and efficient gene therapy platform with several approved products that have marked therapeutic impact for patients. However, a major bottleneck in the development and commercialization of AAV remains the efficiency, cost, and scalability of AA...

Full description

Bibliographic Details
Main Authors:	Michael Florea, Fotini Nicolaou, Simon Pacouret, Eric M. Zinn, Julio Sanmiguel, Eva Andres-Mateos, Carmen Unzu, Amy J. Wagers, Luk H. Vandenberghe
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Molecular Therapy: Methods & Clinical Development
Subjects:	AAV gene therapy adeno-associated purification manufacturing downstream
Online Access:	http://www.sciencedirect.com/science/article/pii/S2329050122001826

Similar Items

Cross-Packaging and Capsid Mosaic Formation in Multiplexed AAV Libraries
by: Pauline F. Schmit, et al.
Published: (2020-06-01)

Characterization of AAV-Specific Affinity Ligands: Consequences for Vector Purification and Development Strategies
by: Mario Mietzsch, et al.
Published: (2020-12-01)

Purification of Adeno-Associated Virus (AAV) Serotype 2 from <i>Spodoptera frugiperda</i> (Sf9) Lysate by Chromatographic Nonwoven Membranes
by: Jinxin Fan, et al.
Published: (2022-09-01)

Thermal Stability as a Determinant of AAV Serotype Identity
by: Antonette Bennett, et al.
Published: (2017-09-01)

Recombinant Adeno-Associated Virus Serotype 6 (rAAV6) Potently and Preferentially Transduces Rat Astrocytes in vitro and in vivo
by: Alexandra L. Schober, et al.
Published: (2016-11-01)

High concordance of ELISA and neutralization assays allows for the detection of antibodies to individual AAV serotypes
by: Matthew R. Gardner, et al.
Published: (2022-03-01)

Advanced biomanufacturing and evaluation of adeno-associated virus
by: Kai Chen, et al.
Published: (2024-02-01)

Preclinical Assessment of Immune Responses to AAV (adeno-associated virus) Vectors
by: Etiena eBasner-Tschakarjan, et al.
Published: (2014-02-01)

Thorough molecular configuration analysis of noncanonical AAV genomes in AAV vector preparations
by: Junping Zhang, et al.
Published: (2024-03-01)

Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry
by: Edward E. Large, et al.
Published: (2021-07-01)

Accelerated Development of AAV Purification Process Using a High-Throughput and Automated Crossflow System
by: Sónia Mendes, et al.
Published: (2024-02-01)

The Structure of an AAV5-AAVR Complex at 2.5 Å Resolution: Implications for Cellular Entry and Immune Neutralization of AAV Gene Therapy Vectors
by: Mark A. Silveria, et al.
Published: (2020-11-01)

AAV vectors accumulate in the pineal gland after injections into the brain or spinal cord
by: Oswald Steward, et al.
Published: (2021-12-01)

Development of a scalable and robust AEX method for enriched rAAV preparations in genome-containing VCs of serotypes 5, 6, 8, and 9
by: Pranav R.H. Joshi, et al.
Published: (2021-06-01)

Multiple-Monitor HPLC Assays for Rapid Process Development, In-Process Monitoring, and Validation of AAV Production and Purification
by: Pete Gagnon, et al.
Published: (2021-01-01)

Immunogenicity of an AAV-Based COVID-19 Vaccine in Murine Models of Obesity and Aging
by: Dawid Maciorowski, et al.
Published: (2022-04-01)

Supraspinal gene transfer by intrathecal adeno-associated virus serotype 5
by: Daniel J. Schuster, et al.
Published: (2014-08-01)

Evaluating Efficiencies of Dual AAV Approaches for Retinal Targeting
by: Livia S. Carvalho, et al.
Published: (2017-09-01)

Humoral immune response to AAV
by: Roberto eCalcedo, et al.
Published: (2013-10-01)

Robust AAV Genotyping Based on Genetic Distances in Rep Gene That Are Maintained by Ubiquitous Recombination
by: Marina I. Beloukhova, et al.
Published: (2022-05-01)

A Small Virus to Deliver Small Antibodies: New Targeted Therapies Based on AAV Delivery of Nanobodies
by: Noelia Silva-Pilipich, et al.
Published: (2021-09-01)

Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes
by: Dzerassa Gurtsieva, et al.
Published: (2024-01-01)

Planet of the AAVs: The Spinal Cord Injury Episode
by: Katerina Stepankova, et al.
Published: (2021-05-01)

Analysis of thermally driven structural changes, genome release, disassembly, and aggregation of recombinant AAV by CDMS
by: Lauren F. Barnes, et al.
Published: (2022-12-01)

A novel class of self-complementary AAV vectors with multiple advantages based on cceAAV lacking mutant ITR
by: Junping Zhang, et al.
Published: (2024-03-01)

Optimizing AAV2/6 microglial targeting identified enhanced efficiency in the photoreceptor degenerative environment
by: Margaret E. Maes, et al.
Published: (2021-12-01)

A versatile toolkit for overcoming AAV immunity
by: Xuefeng Li, et al.
Published: (2022-09-01)

One episode of low intensity aerobic exercise prior to systemic AAV9 administration augments transgene delivery to the heart and skeletal muscle
by: Christina A. Pacak, et al.
Published: (2023-10-01)

Comparison of Different Liquid Chromatography-Based Purification Strategies for Adeno-Associated Virus Vectors
by: Ruth Rieser, et al.
Published: (2021-05-01)

Immunological Monitoring to Rationally Guide AAV Gene Therapy
by: Cedrik Michael Britten, et al.
Published: (2013-09-01)

Molecular Signature of Astrocytes for Gene Delivery by the Synthetic Adeno‐Associated Viral Vector rAAV9P1
by: Amelie Bauer, et al.
Published: (2022-05-01)

AAV-monoclonal antibody expression protects mice from Ebola virus without impeding the endogenous antibody response to heterologous challenge
by: Laura P. van Lieshout, et al.
Published: (2022-09-01)

rAAV Manufacturing: The Challenges of Soft Sensing during Upstream Processing
by: Cristovão Freitas Iglesias, et al.
Published: (2023-02-01)

Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
by: Reetta A. E. Eriksson, et al.
Published: (2022-12-01)

TPP Combined with DGUC as an Economic and Universal Process for Large-Scale Purification of AAV Vectors
by: Zhe Yu, et al.
Published: (2020-06-01)

The HLA class-II immunopeptidomes of AAV capsids proteins
by: Carlos A. Brito-Sierra, et al.
Published: (2022-12-01)

Fantastic AAV Gene Therapy Vectors and How to Find Them—Random Diversification, Rational Design and Machine Learning
by: Jonas Becker, et al.
Published: (2022-07-01)

Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
by: Reetta A. E. Eriksson, et al.
Published: (2023-03-01)

High-Level rAAV Vector Production by rAdV-Mediated Amplification of Small Amounts of Input Vector
by: Stefan Weger
Published: (2022-12-01)

The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
by: Rachel Kelly, et al.
Published: (2021-11-01)